Life Science Investing Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
Life Science Investing Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit
Life Science Investing Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Apollo Silver Announces $2.5 Million Upsize to Previously Announced Financing to Allow for Insider Participation
CORRECTION: Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces $321,917 CEO Investment
